DE3768138D1 - Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase. - Google Patents

Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase.

Info

Publication number
DE3768138D1
DE3768138D1 DE8787106097T DE3768138T DE3768138D1 DE 3768138 D1 DE3768138 D1 DE 3768138D1 DE 8787106097 T DE8787106097 T DE 8787106097T DE 3768138 T DE3768138 T DE 3768138T DE 3768138 D1 DE3768138 D1 DE 3768138D1
Authority
DE
Germany
Prior art keywords
acid
coa
acyltransferase
acyl
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787106097T
Other languages
English (en)
Inventor
Ann Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3768138D1 publication Critical patent/DE3768138D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787106097T 1986-04-28 1987-04-27 Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase. Expired - Fee Related DE3768138D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/856,551 US4722927A (en) 1986-04-28 1986-04-28 Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase

Publications (1)

Publication Number Publication Date
DE3768138D1 true DE3768138D1 (de) 1991-04-04

Family

ID=25323922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787106097T Expired - Fee Related DE3768138D1 (de) 1986-04-28 1987-04-27 Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase.

Country Status (8)

Country Link
US (1) US4722927A (de)
EP (1) EP0245687B1 (de)
JP (1) JPS62258366A (de)
AT (1) ATE61051T1 (de)
CA (1) CA1264747A (de)
DE (1) DE3768138D1 (de)
ES (1) ES2037679T3 (de)
GR (1) GR3001523T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318984A (en) * 1988-12-05 1994-06-07 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5166214A (en) * 1988-12-05 1992-11-24 Du Pont Merck Pharmaceutical Company Use of imidazoles for the treatment of atherosclerosis
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
JPH05320143A (ja) * 1992-03-18 1993-12-03 Mochida Pharmaceut Co Ltd 新規ピリミジン誘導体
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
WO1993024458A1 (en) * 1992-05-28 1993-12-09 Pfizer Inc. New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
EP0609457B1 (de) * 1992-07-20 1997-10-29 Eisai Co., Ltd. Benzolderivate
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
GB2321455A (en) 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US6365411B1 (en) 1999-06-09 2002-04-02 University Of Cincinnati Rain forest plant extract with cellular cholesterol lowering properties
ES2239145T3 (es) * 2000-02-02 2005-09-16 Warner-Lambert Company Llc Inhibidor doble de la sintesis de ester de colesterilo y de ester de cera avasimibe para el tratamiento de trastornos de la glandula sebacea.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5619344B2 (de) * 1972-11-11 1981-05-07
DE2856856A1 (de) * 1978-01-09 1979-07-12 Sandoz Ag Fettsaeure-amid-und-hydracid derivate, ihre herstellung und ihre verwendung als pharmazeutika
CH655717A5 (de) * 1982-09-13 1986-05-15 Sandoz Ag Chloracetamide.
EP0175652A3 (de) * 1984-09-20 1988-07-20 Ciba-Geigy Ag 5-Acylaminopyrimidine

Also Published As

Publication number Publication date
US4722927A (en) 1988-02-02
EP0245687B1 (de) 1991-02-27
EP0245687A1 (de) 1987-11-19
ATE61051T1 (de) 1991-03-15
GR3001523T3 (en) 1992-11-23
ES2037679T3 (es) 1993-07-01
CA1264747A (en) 1990-01-23
JPS62258366A (ja) 1987-11-10

Similar Documents

Publication Publication Date Title
US4716175B1 (de)
DE3768138D1 (de) Substituierte pyrimidinamide von oelsaeure oder linolsaeure als inhibitoren von acyl-coa cholesterin-acyltransferase.
DE3675796D1 (de) Verfahren zur herstellung von entschleimten pflanzlichen oelen und schleim mit hohem gehalt an phosphatidischer saeure.
DE3750710D1 (de) Ester von Alginsäure.
PT91191A (pt) Processo para a lactonizacao de acidos mevinicos e seus analogos
PT82219B (pt) Processo para a extraccao e purificacao de proteinas a partir de meios de cultura que as produzem
DE3855913D1 (de) Gerät zur inspektion von Walzzeichen
DE68924036D1 (de) Mischung von Tallölfettsäuren für Kautschuk.
DE3683729D1 (de) Gegenstand und verfahren zur enzymatischen neutralisierung von wasserstoffperoxyd.
ES2078282T3 (es) Substratos para hidrolasas.
DK152764C (da) Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
IT1197360B (it) Prova di un sistema analogico di comando di processo
DE3682376D1 (de) Verfahren zum anreichern und abscheiden von ungesaettigten fettsaeureestern.
ATE88476T1 (de) Verfahren zur herstellung von 7-aca-derivaten.
DK4786D0 (da) Fremgangsmaade til behandling af biomasse
FI892536A0 (fi) Menetelmä mykoplasmabakteerien laskemiseksi ja toteamiseksi
IT1187671B (it) Procedimento e impianto per il trattamento di emulsioni oleose
DE3886550D1 (de) Verfahren zur kontinuierlichen und selbsttätigen durchführung von analysen und anordnung zur durchführung des verfahrens.
ES2061652T3 (es) Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos.
ATA260682A (de) Verfahren zur herstellung von glyoxylsaeure und von glyoxylsaeurealkylesterhalbacetalen
DE69327984D1 (de) Verfahren zur Modifizierung von Lipasen
DE3578707D1 (de) Herstellungsverfahren von carbonsaeureestern.
ATA144685A (de) Verfahren zur herstellung von proteinen oder enzymen oder von primaeren oder sekundaeren stoffwechselprodukten
ATE30244T1 (de) Verfahren und vorrichtung zur kultivierung von mikroorganismen.
ATE84567T1 (de) Vorrichtungen und verfahren zur kultivierung und pruefung von mikroorganismen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee